Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-12-02 00:00:00 ET · period of report 2025-12-01 · accession 0001061983-25-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-02 | 2025-12-01 | CYTK | Kaye Edward M. MD | Dir | M - OptEx | $13.72 | +28.1K | 18.0K | New | +$385.0K |
| D | 2025-12-02 | 2025-12-01 | CYTK | Kaye Edward M. MD | Dir | S - Sale+OE | $66.72 | -28.1K | 9,977 | -74% | -$1.87M |
| DM | 2025-12-02 | 2025-12-01 | CYTK | Kaye Edward M. MD | Dir | M - OptEx | $0.00 | -28.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | M | A | 20,000 | $14.25 | 38,041 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-01 | M | A | 8,064 | $12.40 | 18,041 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-01 | S | D | 28,064 | $66.72 | 9,977 | D | — | — | |
| 4 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-12-01 | M | D | 20,000 | $0.00 | 0 | D | $14.25 · 2017-06-18 to 2027-05-18 | 20,000 Common Stock | (F2) This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 18, 2018. |
| 5 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-12-01 | M | D | 8,064 | $0.00 | 0 | D | $12.40 · 2017-02-03 to 2027-01-03 | 8,064 Common Stock | (F1) This option shall vest and become exercisable as to 8,064 shares divided into equal monthly installments such that the option shall be 100% vested on January 3, 2018. |